GST Council Considers Legal Backing for Pharma Refunds and Export Status Clarifications
The GST Council is considering proposals to provide legal backing for refund claims by pharmaceutical companies under the inverted duty structure, allowing faster release of tax credits. It may also redefine export status for services like clinical trials and contract manufacturing for foreign clients, enabling tax benefits for such exports. Additional measures include allowing input tax credit on free samples and expired medicines, and extending GST exemptions to imported medicines and specialized foods for rare diseases, aiming to reduce costs and improve clarity for exporters.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (65/100). Lens Score 41/100.
Outlets measured: thefinancialexpress, economictimes, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (58–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 5 Oct, 12:22 pm. Other outlets followed.